- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- hetero-2-2-1-1-mer
- Ligands
- 2 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.2: 2 residues within 4Å:- Chain B: K.251
- Ligands: GTP.1
No protein-ligand interaction detected (PLIP)MG.5: 3 residues within 4Å:- Chain B: Q.10, N.98
- Ligands: GDP.4
No protein-ligand interaction detected (PLIP)MG.11: 3 residues within 4Å:- Chain C: E.71, D.98
- Ligands: GTP.10
No protein-ligand interaction detected (PLIP)MG.14: 3 residues within 4Å:- Chain D: Q.10, N.98
- Ligands: GDP.13
No protein-ligand interaction detected (PLIP)- 2 x CA: CALCIUM ION(Non-covalent)
CA.3: 5 residues within 4Å:- Chain A: D.39, T.41, G.44, D.47, E.55
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.39, A:D.39, A:T.41, A:G.44, A:E.55
CA.12: 4 residues within 4Å:- Chain C: D.39, T.41, G.44, E.55
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:D.39, C:D.39, C:T.41, C:G.44, C:E.55
- 2 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
GDP.4: 18 residues within 4Å:- Chain B: G.9, Q.10, C.11, Q.14, S.137, G.140, G.141, T.142, G.143, V.168, P.170, V.174, S.175, E.180, N.203, Y.221, N.225
- Ligands: MG.5
23 PLIP interactions:23 interactions with chain B- Hydrogen bonds: B:Q.10, B:C.11, B:S.137, B:G.141, B:T.142, B:T.142, B:G.143, B:E.180, B:N.203, B:N.203, B:N.225, B:N.225
- Water bridges: B:Q.10, B:Q.10, B:A.96, B:N.98, B:S.137, B:G.139, B:G.140, B:T.142, B:S.144
- pi-Stacking: B:Y.221, B:Y.221
GDP.13: 18 residues within 4Å:- Chain D: G.9, Q.10, C.11, Q.14, S.137, G.140, G.141, T.142, G.143, V.168, P.170, V.174, S.175, E.180, N.203, Y.221, N.225
- Ligands: MG.14
15 PLIP interactions:15 interactions with chain D- Hydrogen bonds: D:Q.10, D:C.11, D:S.137, D:G.140, D:G.141, D:T.142, D:T.142, D:G.143, D:E.180, D:N.203, D:N.203, D:N.225, D:N.225
- Water bridges: D:G.139, D:S.144
- 1 x LOC: N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[d]heptalen-7-yl]ethanamide(Non-covalent)
LOC.6: 23 residues within 4Å:- Chain A: N.101, S.178, T.179, A.180, V.181
- Chain B: C.238, L.239, L.245, A.247, D.248, K.251, L.252, N.255, M.256, T.311, V.312, A.313, A.314, I.315, N.347, K.349, T.350, A.351
6 PLIP interactions:5 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:A.247, B:K.251, B:L.252, B:N.255, B:A.313
- Hydrogen bonds: A:V.181
- 2 x EP: EPOTHILONE A(Non-covalent)
EP.7: 17 residues within 4Å:- Chain B: L.214, L.216, D.223, H.226, L.227, A.230, F.269, P.271, L.272, T.273, R.275, Q.278, Q.279, Y.280, R.281, L.283, L.360
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:L.216, B:L.227, B:P.271, B:L.272, B:R.275, B:L.360
- Hydrogen bonds: B:D.223
EP.15: 15 residues within 4Å:- Chain D: L.214, L.216, D.223, H.226, L.227, A.230, F.269, P.271, L.272, T.273, S.274, R.275, Q.278, R.281, L.360
12 PLIP interactions:12 interactions with chain D- Hydrophobic interactions: D:L.214, D:L.214, D:L.227, D:F.269, D:P.271, D:L.272, D:T.273, D:R.275, D:L.360
- Hydrogen bonds: D:D.223, D:T.273, D:Q.278
- 1 x POU: Peloruside A(Non-covalent)
- 1 x VLB: (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE(Non-covalent)
VLB.9: 24 residues within 4Å:- Chain B: P.172, K.173, V.174, S.175, D.176, Y.207, F.211, T.217, T.218, P.219, T.220, Y.221, L.224
- Chain C: L.248, P.325, V.328, N.329, I.332, A.333, K.336, F.351, V.353, G.354, I.355
13 PLIP interactions:9 interactions with chain C, 4 interactions with chain B- Hydrophobic interactions: C:P.325, C:V.328, C:I.332, C:I.332, C:F.351, C:V.353, C:I.355, B:Y.221, B:L.224
- Hydrogen bonds: C:N.329, C:N.329, B:P.219
- Salt bridges: B:D.176
- 1 x BKF: (1S,2S,3S,5S,6S,16Z,18Z,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1~10,14~.0~3,5~]hexacosa-10(26),11,13,16,18-pentaen-6-yl 2-methylpropanoate(Non-covalent)
- 1 x ACP: PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER(Non-covalent)
ACP.17: 17 residues within 4Å:- Chain F: K.74, I.148, K.150, Q.183, K.184, Y.185, L.186, K.198, D.200, H.239, L.240, T.241, D.318, M.320, I.330, E.331, N.333
16 PLIP interactions:16 interactions with chain F- Hydrogen bonds: F:K.74, F:K.150, F:Q.183, F:L.186, F:K.198, F:D.200, F:T.241, F:T.241, F:N.242, F:D.318, F:D.318, F:E.331, F:E.331, F:N.333
- Salt bridges: F:K.74, F:K.150
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wranik, M. et al., A multi-reservoir extruder for time-resolved serial protein crystallography and compound screening at X-ray free-electron lasers. Nat Commun (2023)
- Release Date
- 2023-12-13
- Peptides
- Tubulin alpha-1B chain: AC
Tubulin beta-2B chain: BD
Stathmin-4: E
Tubulin tyrosine ligase: F - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
DE
EF
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- hetero-2-2-1-1-mer
- Ligands
- 2 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 2 x CA: CALCIUM ION(Non-covalent)
- 2 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
- 1 x LOC: N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[d]heptalen-7-yl]ethanamide(Non-covalent)
- 2 x EP: EPOTHILONE A(Non-covalent)
- 1 x POU: Peloruside A(Non-covalent)
- 1 x VLB: (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE(Non-covalent)
- 1 x BKF: (1S,2S,3S,5S,6S,16Z,18Z,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1~10,14~.0~3,5~]hexacosa-10(26),11,13,16,18-pentaen-6-yl 2-methylpropanoate(Non-covalent)
- 1 x ACP: PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wranik, M. et al., A multi-reservoir extruder for time-resolved serial protein crystallography and compound screening at X-ray free-electron lasers. Nat Commun (2023)
- Release Date
- 2023-12-13
- Peptides
- Tubulin alpha-1B chain: AC
Tubulin beta-2B chain: BD
Stathmin-4: E
Tubulin tyrosine ligase: F - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
DE
EF
F